Drug intelligence / Profile preview

clopamide

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Clopamide is an oral thiazide-like diuretic and antihypertensive agent. Structurally a piperidine and sulfamoylbenzamide-based compound, it acts similarly to thiazide diuretics but lacks the typical double-ring structure. Its primary mechanism of action is inhibition of the sodium-chloride symporter in the distal convoluted tubule (DCT) of the nephron in the kidney. This leads to reduced reabsorption of sodium and chloride ions, resulting in increased excretion of these electrolytes along with water. The drug is used mainly for treating hypertension (high blood pressure) and edema associated with conditions such as congestive heart failure, liver cirrhosis, or renal disorders[1][2][3][4][5][6]. It is administered orally and has a rapid onset (1–2 hours), with effects lasting up to 24 hours[4]. Common side effects include electrolyte imbalances (such as hypokalemia), dizziness, gastrointestinal disturbances, photosensitivity reactions, and others[3][4].

Brand names
BrinaldixBrinerdinBriserinClopamidTenzimet
Other names
clopamide
02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on clopamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clopamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call